The drug discovery and development process is very costly, risky and time consuming. It requires 8 – 12 years on an average and billions of dollars in investment for developing a molecule from concept to medicine for the benefit of the patients. This interactive webinar co-presented by the experts at Citeline (Formerly Pharma Intelligence) and the Indian Pharmaceutical Alliance (IPA) will help understand the strategic deals and alliances driving Indian pharma R&D and innovation over the last 5 years, with licensing deals between large pharma and smaller biotech companies to bring patient-centric products to market, develop innovative and affordable drugs, and poise India to become a leader in pharma R&D.

свернуть